Vaginal Cytomegalovirus Shedding Before and After Initiation of Antiretroviral Therapy in Rakai, Uganda

Journal of Infectious Diseases

Volumn 212, Issue 6, 2015, Pages 899-903

  Gianella, Sara ^a,h   Redd, Andrew D ^b,c   Grabowski, Mary K ^d   Tobian, Aaron A R ^c,d   Serwadda, David ^e,f   Newell, Kevin ^g   Patel, Eshan U ^b   Kalibbala, Sarah ^e   Ssebbowa, Paschal ^e   Gray, Ronald H ^d,e   Quinn, Thomas C ^b,c   Reynolds, Steven J ^b,c,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^f MAKERERE UNIVERSITY SCHOOL OF PUBLIC HEALTH   (Uganda)

^g FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^h UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

acyclovir; antiretroviral therapy (ART); cytomegalovirus (CMV); human immunodeficiency virus (HIV); immune reconstitution inflammatory syndrome (IRIS); reactivation; Uganda

Indexed keywords

ACICLOVIR; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; PLACEBO; VIRUS DNA; VIRUS RNA; ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FEMALE; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAJOR CLINICAL STUDY; MIXED INFECTION; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UGANDA; VAGINA; VIRUS DETECTION; VIRUS LOAD; VIRUS SHEDDING; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS INFECTIONS; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; HERPES GENITALIS; HERPES SIMPLEX VIRUS 2; HIV INFECTIONS; LONGITUDINAL STUDY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VIROLOGY;

ACYCLOVIR; ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COINFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DOUBLE-BLIND METHOD; FEMALE; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; UGANDA; VAGINA; VIRUS SHEDDING;

EID: 84940732850     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv135     Document Type: Article

References (15)

1. Gianella S, Morris SR, Vargas MV, et al. The role of seminal shedding of herpesviruses in HIV-1 transmission. J Infect Dis 2012; 207:257-61.
2. Johnson EL, Howard CL, Thurman J, Pontiff K, Johnson ES, Chakraborty R. CMV upregulates expression of CCR5 in central memory TCM cord blood mononuclear cells which may facilitate in utero HIV-1 transmission. J Infect Dis 2015; 211:187-96.
3. + T cell activation during antiretroviral treatment. J Virol 2014; 88:7818-27.
4. Mitchell C, Hitti J, Paul K, et al. Cervicovaginal shedding of HIV type 1 is related to genital tract inflammation independent of changes in vaginal microbiota. AIDS Res Hum Retroviruses 2011; 27:35-9.
5. Schoenfisch AL, Dollard SC, Amin M, et al. Cytomegalovirus (CMV) shedding is highly correlated with markers of immunosuppression in CMV-seropositive women. J Med Microbiol 2011; 60:768-74.
6. Mostad SB, Kreiss JK, Ryncarz AJ, et al. Cervical shedding of cytomegalovirus in human immunodeficiency virus type 1-infected women. J Med Virol 1999; 59:469-73.
7. Silver MI, Paul P, Sowjanya P, et al. Shedding of Epstein-Barr virus and cytomegalovirus from the genital tract of women in a periurban community in Andhra Pradesh, India. J Clin Microbiol 2011; 49:2435-9.
8. Broccolo F, Cassina G, Chiari S, et al. Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women. J Med Virol 2008; 80:147-53.
9. Reynolds SJ, Makumbi F, Newell K, et al. Effect of daily aciclovir on HIV disease progression in individuals in Rakai, Uganda, co-infected with HIV-1 and herpes simplex virus type 2: a randomised, double-blind placebo-controlled trial. Lancet Infect Dis 2012; 12:441-8.
10. Celum C, Wald A, Lingappa JR, et al. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 2010; 362:427-39.
11. Tobian AA, Grabowski MK, Serwadda D, et al. Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy. J Infect Dis 2013; 208:839-46.
12. Heagerty PJ, Zeger SL. Lorelogram: a regression approach to exploring dependence in longitudinal categorical responses. J Am Stat Assoc 1998; 93:150-62.
13. Muller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M. Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10:251-61.
14. French MA. HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. Clin Infect Dis 2009; 48:101-7.
15. Hunt PW. HIV and inflammation: mechanisms and consequences. Curr HIV/AIDS Rep 2012; 9:139-47.